DBCO-PEG4-VC-PAB-MMAE
Based on 2 publication(s) in Google Scholar
DBCO-PEG4-VC-PAB-MMAE consists a ADC linker (DBCO-PEG4-VC-PAB) and a tubulin polymerization inhibitor MMAE (HY-15162). DBCO-PEG4-VC-PAB-MMAE can be used in the synthesis of antibody-agent conjugates (ADCs). MMAE is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. DBCO-PEG4-VC-PAB-MMAE is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
For research use only. We do not sell to patients.
- Purity: 99.53%
- CAS No.: 2129164-91-4
- Formula: C88H128N12O19
- Molecular Weight:1658.03
-
Storage:
-20°C, protect from light, stored under nitrogen
* The compound is unstable in solutions, freshly prepared is recommended.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) DBCO-PEG4-VC-PAB-MMAE
MoreAll Drug-Linker Conjugates for ADC Isoforms
More
Biological Activity
|
Duocarmycins |
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2129164-91-4
-
Appearance Solid
-
Molecular Weight 1658.03
-
Formula C88H128N12O19
-
Color White to off-white
-
SMILES
CC[C@H](C)[C@@H]([C@@H](CC(N1[C@@H](CCC1)[C@@H]([C@@H](C)C(N[C@H](C)[C@@H](O)C2=CC=CC=C2)=O)OC)=O)OC)N(C([C@H](C(C)C)NC([C@H](C(C)C)N(C(OCC3=CC=C(NC([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC(CCOCCOCCOCCOCCNC(CCC(N4CC5=C(C=CC=C5)C#CC6=C4C=CC=C6)=O)=O)=O)=O)=O)C=C3)=O)C)=O)=O)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, protect from light, stored under nitrogen
* The compound is unstable in solutions, freshly prepared is recommended.
Publications (2)
-
Journal Impact Factor
-
Most Recent
Solvent & Solubility
DMSO : ≥ 100 mg/mL (60.31 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.
Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 0.6031 mL | 3.0156 mL | 6.0313 mL | 15.0781 mL |
| 5 mM | 0.1206 mL | 0.6031 mL | 1.2063 mL | 3.0156 mL | |
| 10 mM | 0.0603 mL | 0.3016 mL | 0.6031 mL | 1.5078 mL | |
| 15 mM | 0.0402 mL | 0.2010 mL | 0.4021 mL | 1.0052 mL | |
| 20 mM | 0.0302 mL | 0.1508 mL | 0.3016 mL | 0.7539 mL | |
| 25 mM | 0.0241 mL | 0.1206 mL | 0.2413 mL | 0.6031 mL | |
| 30 mM | 0.0201 mL | 0.1005 mL | 0.2010 mL | 0.5026 mL | |
| 40 mM | 0.0151 mL | 0.0754 mL | 0.1508 mL | 0.3770 mL | |
| 50 mM | 0.0121 mL | 0.0603 mL | 0.1206 mL | 0.3016 mL | |
| 60 mM | 0.0101 mL | 0.0503 mL | 0.1005 mL | 0.2513 mL |
DBCO-PEG4-VC-PAB-MMAE Related Classifications
HY-136314 Related Classifications
Powered by Bioz